Guidelines Updated for Administration of Combination MMRV Vaccine

The updated ACIP recommendation now reads as follows: "Combination MMRV vaccine is approved for use among healthy children aged 12 months – 12 years. MMRV vaccine is indicated for simultaneous vaccination against measles, mumps, rubella, and varicella. ACIP does not express a preference for use of MMRV vaccine over separate injections of equivalent component vaccines (i.e., MMR vaccine and varicella vaccine)."

The ACIP also advocated that a work group be convened for in-depth analysis of data regarding the increased risk for febrile seizures after the first dose of MMRV vaccine. On the basis of these findings and other information that becomes available, the CDC, FDA, and ACIP will consider future policy options, communicate updates, and implement further necessary actions.

If you want to read it in details, please visit the following website at the address given below.
http://www.medscape.com/viewarticle/571507
--
Dr Marwah